Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Genetic Technologies ( (AU:GTG) ).
Genetic Technologies has abandoned its planned acquisition of Ellerfield Private Wealth, formerly Ellerfield Wealth and Walker Capital Private Wealth, after a strategic review by the Board. The company will instead prioritise alternative transactions that better support its proposed relisting strategy and has indicated it is assessing multiple opportunities, with further market updates to follow as these options progress.
The most recent analyst rating on (AU:GTG) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Genetic Technologies stock, see the AU:GTG Stock Forecast page.
More about Genetic Technologies
Genetic Technologies Limited is an Australia-based company listed on the ASX that operates in the genetics and biotechnology sector. The company focuses on developing and commercialising genetic testing and related technologies, positioning itself within the broader life sciences and precision health markets.
Technical Sentiment Signal: Sell
Current Market Cap: A$5.67M
For detailed information about GTG stock, go to TipRanks’ Stock Analysis page.